| Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
| |
| HDFC Pharma and Healthcare Fund Reg (G) |
| [Equity: Sectoral] |
|
| |
|
|
| Instruments Breakdown |
| Instruments |
Composition |
| Current Asset |
0.79 |
| Equity |
97.30 |
| Trep |
1.91 |
|
| |
| Concentration Analysis |
| Top 5 Holdings |
34.67% |
| Top 10 Holdings |
58.03% |
| Top 25 Holdings |
93.40% |
|
|
|
| |
| Sector Analysis |
| Sector/Ratings |
Net Asset(%) |
| Pharma & Biotech |
70.09 |
| Healthcare |
27.21 |
| Cash |
2.7 |
|
|
|
|
|
| Portfolio Metrics |
|
| PB Ratio |
6.36 |
| PE Ratio |
48.80 |
|
| |
| Top 25 Holdings |
|
|
| Holdings |
Net Asset(%) |
| DIVI LABORATORIES LTD |
8.56 |
| Sun Pharmaceutical Industries Limited |
8.05 |
| Lupin Limited |
6.07 |
| Glenmark Pharmaceuticals Limited |
6.06 |
| Max Healthcare Institute Limited |
5.93 |
| (5) Total outstanding exposure in derivative instruments as on April 30, 2026 is Rs. Nil. |
5.46 |
| Alkem Laboratories Limited |
4.69 |
| Anthem Biosciences Limited |
4.55 |
| IPCA Laboratories Limited |
4.39 |
| Cipla Limited |
4.27 |
| ACUTAAS CHEMICALS LIMITED |
4.07 |
| Fortis Health Care Ltd |
3.71 |
| Krishna Inst of Medical Sciences Ltd. |
3.04 |
| Laurus Labs Limited |
2.80 |
| VIJAYA DIAGNOSTIC CENTRE LIMITED |
2.55 |
| Metropolis Healthcare Limited |
2.39 |
| EQ- GLOBAL HEALTH LTD. |
2.21 |
| Torrent Pharmaceuticals Limited |
2.13 |
| Shilpa Medicare Limited |
2.04 |
| Neuland Laboratories Limited |
1.97 |
| TREPS - Tri-party Repo |
1.91 |
| Sai Life Sciences Limited |
1.79 |
| Wockhardt Limited |
1.67 |
| Eris Lifesciences Limited |
1.66 |
| Rubicon Research Limited |
1.43 |
|
|
|
| |
|
| |
| Sector Analysis Graphical Mode |
|
| |
|
|
| |
|
 |
| |
|
|
|
